Found 43 HIV trials
A listing of HIV medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to measure the safety, reactogenicity, and immunogenicity of VIR 1388 in adults in good health without HIV.
A5394 is a phase II, randomized, double-blind, placebo-controlled clinical trial to assess the safety, tolerability, and efficacy of 24 weeks of treatment with Selgantolimod (SLGN). Intensive PK sampling will be conducted in the first 12 participants who enroll into the study.
Our pilot study will evaluate whether the activation of antiviral innate mechanisms by administration of Pegylated Interferon alpha 2b (peg-IFN-2b) when combined with two broadly neutralizing antibodies (3BNC117 and 10-1074) in HIV positive participants with well controlled viral replication can result in viral control in the absence of ART or …
The main purpose of this study is to see if it is safe to give people 10-1074-LS and 3BNC117-LS and to see if these study drugs cause any side effects. We also want to see how the study drugs affect the level of HIV in the blood when you are …
This is a Phase 2, randomized, open-label, active-controlled, multicenter study to evaluate the safety, efficacy, and PK of ISL + LEN. The target population is virologically suppressed people living with HIV (PWH) who are at least 18 years of age and meet other study inclusion criteria. All participants will be …
This research study will help us see whether providing medical services in a mobile unit will help persons who inject drugs (PWID) start and stay on anti-HIV medicines and medicines for opioid use disorder better.
Section 3 HYPOTHESES, OBJECTIVES, AND ENDPOINTS p42-47 in the attached protocol Section 3 HYPOTHESES, OBJECTIVES, AND ENDPOINTS p42-47 in the attached protocol Section 4 STUDY DESIGN p47-56 in the attached protocol Section 3 HYPOTHESES, OBJECTIVES, AND ENDPOINTS p42-47 in the attached protocol Section 4 STUDY DESIGN p47-56 in the attached …
Some samples (for example, blood, tissue, fluids) taken from you during this or another research study might be useful for research at some later date. This study is being done so that your samples can be stored and used at some later date for research studies, including genetic testing. These …
This trial is testing doravirine/islatravir (also known as MK-8591A or DOR/ISL) in people living with HIV-1 who have participated in another Merck-sponsored trial of DOR/ISL. The main purpose of this trial is to test the safety and efficacy of DOR/ISL and give patients continued access to DOR/ISL through this rollover …
Section 3 HYPOTHESES, OBJECTIVES, AND ENDPOINTS page 35 in the attached protocol. Section 4 STUDY DESIGN page 36-39 in the attached protocol. Section 4 STUDY DESIGN page 36-39 in the attached protocol.
